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Abstract  
Background: High quality data is critical to the entire scientific enterprise, yet the 
complexity and effort involved in data curation is vastly under-appreciated.   This is 
especially true for large observational, clinical studies because of the amount 
of multimodal data that is captured and the opportunity for addressing numerous 
research questions through analysis, either alone or in combination with other data 
sets.  However, a lack of details concerning data curation methods can result in 
unresolved questions about the robustness of the data, its utility for addressing specific 
research questions or hypotheses, and how to interpret the results. We aimed to 
develop a framework for the design, documentation and reporting of data curation 
methods in order to advance the scientific rigor, reproducibility, and analysis of the data. 
Methods: Forty-six experts participated in a modified Delphi process to reach 
consensus on indicators of data curation that could be used in the design and reporting 
of studies. Results:  We identified 46 indicators that are applicable to the design, 
training/testing, run-time and post-collection phases of studies.  Conclusion: The Data 
Acquisition, Quality and Curation for Observational Research Designs (DAQCORD) 
Guidelines are the first comprehensive set of data quality indicators for large 
observational studies.  They were developed around the needs of neuroscience 
projects, but we believe they are relevant and generalizable, in whole or in part, to other 
fields of health research, and also to smaller observational studies and preclinical 
research.  The DAQCORD Guidelines provide a framework for achieving high quality 
data; a cornerstone of health research.
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Introduction  
Observational studies are a crucial part of the biomedical research armamentarium, 
particularly when studying complex conditions or the related problem of understanding 
the outcomes of interventions in highly heterogeneous real-world populations.1  As well 
as generalizability, the cost benefit ratio of enrolling a subject in observational studies is 
relatively low, which makes feasible the recruitment of  large samples potentially 
needed to reliably identify modest, but clinically important differences. This scalability, 
alongside the availability of electronic case-report form (eCRF) platforms and increasing 
availability of routinely collected data in electronic form means that it is possible to 
devise large, multicentre / multinational observational projects.  
With open or shared access to data becoming increasingly common, including with 
funding agencies, it is likely that large observational datasets will become important 
resources for future secondary analysis by external investigators. For example, a recent 
comparative effectiveness study in traumatic brain injury2 was designed to prospectively 
acquire demographic, longitudinal clinical and intervention, outcome, biomarker, ‘omics, 
imaging and waveform data in 5,400 patients in three strata from multiple sites in 22 
countries.  This dataset alone comprises more than 2,500 discrete data concepts, but in 
addition, it is designed to be compatible with data from sister studies in the USA, 
Australia, India and China. This combination of scale, structure and data types makes 
such initiatives highly complex, technical challenges.   
Even electronically collected clinical data may comprise a diverse mixture of data types 
and sources, and combinations of single, repeated measures, as well as time series, 
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which may be irregularly sampled. Combining this with ‘omics, waveform recordings or 
imaging data introduces yet another tier of structural complexity. The involvement of 
multiple sites, particularly where these are international, may introduce further data 
variances due to local interpretation of procedures and linguistic and cultural 
misunderstandings. Notwithstanding incomplete data standards, real-world data from 
even a well conducted study will inevitably contain errors or limitations that can only be 
understood in the context of the precise study structure. An understanding of this is 
crucial to making robust inferences and therefore also to repeatability. Furthermore, 
without detailed meta-data, this knowledge can reside only with the study team, limiting 
transparency and making secondary analysis potentially subject to bias or other 
misinterpretations.  
Data curation is clearly important, but the complexity and effort involved is under-
appreciated and this may have serious scientific repercussions on the entire data 
sharing/open science enterprise. Poor attention to detail from design through execution 
including quality control and curation may severely limit data interpretation and 
consequently re-use and transparency. For prospective studies, post factum curation 
may improve data usability but retrospective correction of issues that emerge during the 
collection period is at best time consuming and may be impossible. Thus, data quality 
efforts should start at study design phase. Even the timely detection of emergent data 
quality issues is predicated on an understanding of both the data structure and study 
structure and will be severely hampered if these are not carefully specified.  
Since a lack of attention to data quality and curation throughout the study may not only 
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degrade data quality, but also limit the validity of primary and subsequent analyses, an 
appraisal of this is important in evaluating study quality. Initiatives such as the 
Strengthening the Reporting of Observational studies in Epidemiology (STROBE)  
guidelines3 aim to improve transparency and reproducibility in observational research. 
However, STROBE primarily addresses crucial conceptual and statistical rigour. A more 
recent extension to STROBE, the REporting of studies Conducted using Observational 
Routinely-collected Data (RECORD) checklist4 touches on data quality in the context of 
routine data. However, neither of these excellent initiatives directly address the equally 
critical question of the extent or adequacy of the steps taken to ensure the data is high 
quality, or to more fully inform a reader of any potential limitations to the analysis 
resulting from the curation process. This also means that study designers lack a 
prospective framework from which to devise (and budget) the necessary comprehensive 
data quality strategy at study conception and design.  
The Data Acquisition, Quality and Curation for Observational Research Designs 
(DAQCORD) Guidelines were developed for investigators conducting large 
observational research studies to aid the design, documentation and reporting of 
practices for assuring data quality within their studies. This information is intended to 
provide guidance and a transparent reporting framework for improving data quality and 
data sharing. Given the absence of a structured framework for the description and 
appraisal of the collection and curation process, the DAQCORD Collaboration aims to 
address these issues and has three key aims.  
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1. To provide a framework / toolkit for robust study design (and eCRF design in 
particular) and data quality management.  
2. To provide a framework by which proposed study plans can be systematically 
appraised (for example by funding organisations) in terms of their approach to data 
quality.  
3. To provide a reporting framework with which to describe the steps taken to ensure 
data quality in the final study publication.  
Methods  
Development of the DAQCORD Indicators 
The DAQCORD project was initiated in 2017, originally arising from discussion of data 
management issues in the InTBIR5 consortium. This consortium includes observational 
studies which are representative of the most ambitious staged to date in the field of 
traumatic brain injury with respect to the number of patients and complexity of the data 
collected. Funding / technical support was obtained to facilitate a face-to-face 
consensus meeting as well as the necessary survey infrastructure and website 
(www.daqcord.org). Our methodology was designed in accordance with best practice 
published by the Equator network6 with which the initiative was registered. We formed a 
Steering Committee consisting of seven individuals with professional backgrounds in 
informatics and data management and/or experience in data curation / dataset design in 
large scale observational studies. A summary of the steps involved in developing the 
DAQCORD indicators is shown in the Figure. 
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The Steering Committee performed a search of literature for relevant publications on 
data quality methodology for large observational and heterogeneous studies.  Sources 
consulted included PubMed, Ovid-Medline, Web-of-Science and Google Scholar, and 
we followed this up by hand searching specific journals. The search identified a range of 
informing literature, including a body of work concerning data collected during routine 
care7-10; however, we were unable to identify any peer-reviewed publications giving 
systematic practical advice on data quality methodology for observational studies (i.e. 
studies with a typical cycle of design, implementation, and post-collection). The Steering 
Committee generated an initial set of 106 items potentially relevant to data quality that 
were derived from published sources, including transferable concepts identified by the 
Steering Committee from our literature search,11-17 unpublished manuals on data 
curation provided by studies within the InTBIR consortium, previously published Equator 
guidelines, and from personal experience. We carried out an initial exercise within the 
Steering Committee to categorize questions on the data quality factors of completeness, 
correctness, concordance, plausibility, and currency (Weiskopf and Weng7 see Table 1 
for definitions of these terms) and evaluate the importance of individual items. Items 
were reviewed for duplication and overlap and were removed or re-written as 
necessary. As a result of this initial exercise, the number of items was reduced to 68 
and the remaining items were edited for clarity.  
The Steering Committee agreed a Delphi approach to reach consensus on the 
DAQCORD tool was appropriate, with the modification of having a face-to-face meeting 
of the panel in addition to circulation of material.  A meeting was judged vital to allow in-
depth discussion of the aims and outcomes of the project as well as the criteria and 
https://doi.org/10.1017/cts.2020.24
Downloaded from https://www.cambridge.org/core. IP address: 92.41.238.143, on 01 Jun 2020 at 18:43:50, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
boundaries applied to item selection. The 68 items were collated into an on-line 
structured questionnaire for rating by panel members, and a consensus conference was 
held in September 2018 at the National Institutes of Health, Bethesda. There was a 
range of expertise among the 46 panel participants, including nine bioinformaticists/ 
computer scientists, eight data managers/ data scientists, seven epidemiologists/ 
statisticians, fifteen clinician/researchers, and seven biomedical scientists. The majority 
were from the U.S. (29), with nine from Europe and eight from Canada. Participants 
also represented a range of organizations, including 33 from academia, eight from 
government, three from non-profit organisations, and two from industry. Respondents 
were chosen to be representative of a range of career stages from principal 
investigators to earlier stage researchers. 
At the consensus meeting we discussed the criteria used to assess the suitability of 
items for assessing data quality; the criteria agreed were validity, feasibility, and 
actionability. The three criteria were elaborated as follows: ‘validity’ means that ‘the 
metric is likely to reflect data quality’, ‘feasibility’ means ‘this is something that can be 
measures or assessed, and is quantifiable’, and  ‘actionability’ means that ‘improving 
this metric could be used in practice to make changes to a study that improves data 
quality’. We also discussed whether additional items were required, the potential 
applications of the instrument, and strategies for disseminating the outputs of the 
project. The consensus meeting allowed greater convergence on key issues and more 
detailed feedback on responses than would have been possible using only on-line 
questionnaires.  
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In the separate rounds of the Delphi panel members rated items on whether they met 
each criterion using a Likert-type scale from 1 (strongly disagree) to 5 (strongly agree). 
A formal procedure was agreed for adopting and rejecting items on the basis of ratings 
which was in keeping with methods which have been previously employed and found to 
provide consensus 18, 19. A median score ≥ 4 for agreement was considered a good 
rating for the dimension while ≤ 3 was a neutral or poor rating. In addition, an 
interquartile range of 0 or 1 was regarded as very good consensus on the rating, 2 as 
good consensus, and more than 2 as a lack of consensus. To be accepted, an item 
needed a good rating on each dimension and a good consensus on each rating (or very 
good consensus for the ‘validity’ dimension), items were rejected if they had a low rating 
on one or more dimensions with good consensus, and otherwise they were carried 
forward to the next round. The criteria adopted for ‘validity’ ratings were stricter because 
this dimension was regarded as critical to the usefulness of the item. No upper or lower 
boundary was set on the number of items that would be accepted. Respondents could 
also make free text comments, which were included in the feedback to participants. At 
each stage items were also edited for precision or duplication as a result of responses 
from participants. Respondents were able to see results for each item in each domain 
from previous rounds.  
Results 
The Delphi process converged on 46 items after three rounds that were judged to be 
indicators of data quality. (See Figure). The 46 items (henceforth referred to as 
indicators) included in the final set all had median ratings for validity, feasibility, and 
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actionability of 4 or 5 indicating agreement or strong agreement that the component met 
the criterion. All the indicators also showed good consensus after three rounds. The 
final DAQCORD components are categorized and listed by data quality factors (i.e.  
completeness, correctness, concordance, plausibility, and currency) with the relevant 
study phase for implementation noted in a separate column (see Table 2).   
Supplementary material, including the DAQCORD indicators with examples derived 
from the Delphi exercise, is also presented on line (https://www.daqcord.org/daqcord-
questions/).  
The DAQCORD indicators are intended as a descriptive system for planning and 
reporting observational studies. At a minimum, they can be used as a checklist for 
documenting whether an indicator is being addressed fully, partially or not at all. A more 
extended and informative record can be made by users through creation of a brief 
narrative for each indicator describing how this was addressed for their study. The 
resulting text will provide formal documentation of the data quality steps taken for the 
study, which will serve as an evidential record that can inform funders and the research 
community. 
Discussion  
The DAQCORD Guidelines were developed to help authors in reporting on large 
observational studies and to assist readers and reviewers in appraising data quality in 
published studies and of the dataset as a whole. Furthermore, the Guidelines aim to 
provide a prospective framework to encourage comprehensive best practice in the 
design of a data quality strategy from the outset to ensure that the data ultimately 
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collected is of as high a quality as possible, to streamline and limit the need for costly 
retrospective curation, as well as to improve transparency and facilitate meaningful 
open access and re-use. It may also provide a structure for funding agency review of 
proposed data quality strategies.  
DAQCORD was developed by a panel selected for its comprehensive expertise in the 
practical design and issues encountered in large data-heavy observational studies. It is 
likely that observational datasets will grow in complexity and scope in the future and it is 
conceivable that new challenges (or indeed data platforms and standards) will emerge 
and consequently DAQCORD will need to be revised in the light of such developments.  
Observational studies are, by their nature, heterogeneous in their domains, aims and 
scope and therefore not all elements will be relevant to all study designs. At the same 
time, we believe that where they are applicable, the indicators that we have developed 
provide a systematic framework for addressing potential data quality issues. It is not our 
aim to prescriptively specify the steps necessary for all studies. Indeed, given the 
heterogeneity of such studies, we do not believe that this is possible. There may be 
many, equally valid, ways in which a particular study may address (or demonstrate that 
it has addressed) any particular aspect of data curation.  As part of the Delphi process, 
we also gathered examples of possible best practice for each indicator: these are 
available on-line to serve as a guide and further elaboration.  We also envision this a 
‘living resource’, which could be expanded on to include more indicators for selected 
types of data, i.e., electronic health records, preclinical research, qualitative data (e.g. 
derived from interviews and surveys), neuroimaging, biospecimens, continuous 
physiological measurements, etc.  
The indicators are weighted towards measures that should be implemented at design-
time. In our experience the challenges presented by large-scale projects may be under-
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appreciated at project inception. In particular the amount of funding that needs to be 
allocated to data quality processes may be underestimated.  Grant giving bodies could 
play a key role in identifying this shortfall at proposal stage and ensuring that it is 
adequately addressed. 
We recognize that there are likely to be limitations to the retrospective application of the 
Guidelines to existing datasets. For some studies the details of the steps taken during 
data curation may not be available.  It may also be appropriate to be tolerant when 
applying criteria post-hoc, since the original study may not have had the resources to 
adequately address data curation at the time. Issues in such databases may be 
addressed over time, for example, through documentation of known problems by 
researchers.  
DAQCORD set out to address the issues of large-scale, complex observational studies, 
explicitly including the design of the data capture infrastructure such as electronic case 
report forms since this is an area which is highly complex and potentially problematic. A 
large proportion of the Delphi collaborators are from neurosciences backgrounds. This 
domain has seen some of the most complex datasets from large scale multinational 
observational studies and therefore this community has necessarily developed a 
substantial expertise in this area. However, we believe that the concepts are 
generalizable to other clinical disorders, and smaller clinical and preclinical studies, as 
well.  In summary, we believe that the DAQCORD Guidelines will enhance the design 
and management of biomedical research studies, provide assurance to potential 
collaborators about data quality, and promote collaborative research to improve 
healthcare on a global scale. 
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 Table 1: Key Terms and Concepts 
Term Definition in the context of use for the DAQCORD Guidelines 
Actionability The indicator can be acted upon in the data curation process to 
assure quality. 
Completeness The degree to which the data was in actuality collected in 
comparison to what was expected to be collected.  
Concordance The agreement between variables that measure related factors. 
Correctness The accuracy of the data and its presentation in a standard and 
unambiguous manner. 
Currency The timeliness of the data collection and representativeness of a 
particular time point.  
Curation The management of data throughout its lifecycle (acquisition to 
archiving) to enable reliable reuse and retrieval for future research 
purposes. 
Data Information that is collected and stored electronically for primary 
and secondary analysis of health-related research.  
Data quality 
factors  
The completeness, correctness, concordance, plausibility, and 
currency of data 
Feasibility Information about the indicator is available or easy to obtain. 
Indicator A measurable variable that is used to represent the quality of the 
data curation methods. 
Observational 
study 
Any research study involving data collection without a manipulation 
or intervention 
Plausibility The extent to which data are consistent with general medical 
knowledge or background information and are therefore believable 
Validity The indicator reflects the quality of the data curation methods used 
in the research.  
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Table 2. DACQORD Indicators. 
 
Study Phase Dimension Indicator 
Design-time Correctness 1. The case report form (CRF) has been designed by a team with a range of expertise. 
Design-time Completeness 
2. There is a robust process for choosing and designing the dataset to be collected that 
involves appropriate stakeholders, including a data-curation team with appropriate skill 
mix. 
Design-time Concordance 
3. The data ontology is consistent with published standards (common data elements) to 
the greatest extent possible. 
Design-time Concordance 4. Data-types are specified for each variable. 
Design-time Correctness 5. Variables are named and encoded in a way that is easy to understand. 
Design-time Representation 
6. Relational databases have been appropriately normalised: steps have been taken to 
eliminate redundant data and remove potentially inconsistent or overly complex data 
dependencies. 
Design-time Representation 7. Each individual has a unique identifier. 
Design-time Representation 
8. There is no duplication in the data set: data has not been entered twice for the same 
participant. 
Design-time Completeness 
9. Data that is mandatory for the study is enforced by rules at data entry and user reasons 
for overriding the error checks (queries) are documented in the database. 
Design-time Completeness 
10. Missingness is defined and is distinguished from ‘not available’, ‘not applicable’, ‘not 
collected’ or ‘unknown.’ For optional data, ‘not entered’ is differentiated from ‘not 
clinically available’ depending on research context. 
Design-time Plausibility 
11. Range and logic checks are in place for CRF response fields that require free entry of 
numeric values. Permissible values and units of measurement are specified at data entry. 
Design-time Correctness 
12. Free text avoided unless clear scientific justification and (e.g. qualitative) analysis plan 
specified and feasible. 
Design-time Concordance 
13. Database rule checks are in place to identify conflicts in data entries for related or 
dependent data collected in different CRFs or sources. 
Design-time Representation 
14. There are mechanisms in place to enforce / ensure that time-sensitive data is entered 
within allotted time windows. 
Design-time Completeness 15. There is clear documentation of interdependence of CRF fields, including data entry 
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skip logic. 
Design-time Correctness 
16. Data collection includes fields for documenting that participants meet inclusion/ 
exclusion criteria. 
Design-time Representation 
17. The data entry tool does not perform rounding or truncation of entries that might 
result in precision-loss. 
Design-time Plausibility 
18. Extract / transform / load software for batch upload of data from other sources such 
as assay results should flag impossible and implausible values. 
Design-time Representation 
19. Internationalisation is undertaken in a robust manner, and translation and cultural 
adaption of concepts (e.g. assessment tools) follows best practice. 
Design-time Concordance 
20. Data collection methods are documented in study manuals that are sufficiently 
detailed to ensure the same procedures are followed each time. 
Design-time Correctness 
21. All personnel responsible for entering data receive training and testing on how to 
complete the CRF. 
Design-time Correctness 
22. The CRF / eCRF are easy to use and include a detailed description of the data collection 
guidelines and how to complete each field in the form. They are pilot tested in a rigorous 
pre-specified and documented process until reliability and validity are demonstrated. 
Design-time Concordance 
23. Data collectors are tested and provided with feedback regarding the accuracy of their 
performance across all relevant study domains. 
Design-time Correctness 
24. Data collection that requires specific content expertise is carried out by trained and/or 
certified investigators. 
Design-time Correctness 
25. Assessors are blinded to treatment allocation or predictor variables where appropriate 
and such blinding is explicitly recorded. 
Design-time Correctness 
26. There is a clear audit chain for any data processing that takes place after entry, and 
this should have a mechanism for version control if it changes. 
Design-time Representation 27. Data are provided in a form that is unambiguous to researchers. 
Design-time Concordance 28. For physiological data the methods of measurement and units are defined for all sites. 
Design-time Correctness 29. Imaging acquisition techniques are standardised (e.g. magnetic resonance imaging). 
Design-time Correctness 30. Biospecimen preparation techniques are standardised. 
Design-time Correctness 
31. Biospecimen assay accuracy, precision, repeatability, detection limits, quantitation 
limits, linearity and range are defined. Normal ranges are determined for each assay. 
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Design-time Correctness 32. There is automated entry of the results of biospecimen samples 
Training and 
Testing 
Completeness 
33. A team of data-curation experts are involved with pre-specified initial and ongoing 
testing for quality assurance. 
Run-time Completeness 
34. Proxy responses for factual questions (such as employment status) are allowed in 
order to maximize completeness. 
Run-time Representation 
35. Automated variable transformations are documented and tested before 
implementation and if modified. 
Run-time Completeness 
36. There is centralized monitoring of the completeness and consistency of information 
during data collection. 
Run-time Plausibility 
37. Individual data elements should be checked for missingness. This should be done 
against pre-specified skip-logic / missingness masks. This should be performed throughout 
the study data acquisition period to give accurate ‘real time’ feedback on completion 
status. 
Run-time Plausibility 38. Systematic and timely measures are in place to assure ongoing data accuracy. 
Run-time Correctness 
39. Source data validation procedures are in place to check for agreement between the 
original data and the information recorded in the database. 
Run-time Plausibility 
40. Reliability checks have been performed on variables that are critical to research 
hypotheses, to ensure that information from multiple sources is consistent. 
Run-time Correctness 41. Scoring of tests is checked. Scoring is performed automatically where possible. 
Run-time Correctness 
42. Data irregularities are reported back to data collectors in a systematic and timely 
process. There is a standard operating procedure for data irregularities to be reported 
back to the data collectors and for documentation of the resolution of the issue 
Run-time Representation 
43. Known/emergent issues with the data dictionary are documented and reported in an 
accessible manner. 
Post-collection Representation 44. The version lock-down of the database for data entry is clearly specified. 
Post-collection Correctness 45. A plan for ongoing curation and version control is specified. 
Post-collection Representation 46. A comprehensive data dictionary is available for end users. 
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Figure: Flow diagram for the DAQCORD modified Delphi process 
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